FOLLOWUS
Effects of Ligustrazine on Airway Inflammation in A Mouse Model of Neutrophilic Asthma
Effects of Ligustrazine on Airway Inflammation in A Mouse Model of Neutrophilic Asthma
- 中国结合医学杂志（英文版） 2018年24卷第5期 页码：353-358
- Affiliations：
1. Department of Geriatric Medicine, the Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Ji’nan,China
2. Department of Respiratory Medicine, the Second Hospital of Shandong University, Ji’nan,China
- Author bio：
- Funds：Supported by the Key Scientific and Technological Project of Shandong Province (No. 2014GSF119012), China
DOI：10.1007/s11655-017-2830-0
中图分类号：纸质出版日期：2018，
网络出版日期：2017-10-30，
Scan for full text
Liu, Xm., Wang, Yb., Wu, Q. et al. Effects of Ligustrazine on Airway Inflammation in A Mouse Model of Neutrophilic Asthma., Chin. J. Integr. Med. 24, 353–358 (2018). https://doi.org/10.1007/s11655-017-2830-0
Xiao-ming Liu, Yong-bin Wang, Qian Wu, et al. Effects of Ligustrazine on Airway Inflammation in A Mouse Model of Neutrophilic Asthma[J]. Chinese Journal of Integrative Medicine, 2018,24(5):353-358.
Liu, Xm., Wang, Yb., Wu, Q. et al. Effects of Ligustrazine on Airway Inflammation in A Mouse Model of Neutrophilic Asthma., Chin. J. Integr. Med. 24, 353–358 (2018). https://doi.org/10.1007/s11655-017-2830-0 DOI：
Xiao-ming Liu, Yong-bin Wang, Qian Wu, et al. Effects of Ligustrazine on Airway Inflammation in A Mouse Model of Neutrophilic Asthma[J]. Chinese Journal of Integrative Medicine, 2018,24(5):353-358. DOI： 10.1007/s11655-017-2830-0.
摘要
To investigate the effects of ligustrazine (LTZ) on airway inflammation in a mouse model of neutrophilic asthma (NA). Forty healthy C57BL/6 female mice were randomly divided into 4 groups using a random number table
including the normal control
NA
LTZ and dexamethasone (DXM) groups
with 10 rats in each group. The NA mice model was established by the method of ovalbumin combined with lipopolysaccharide sensitization. At 0.5 h before each challenge
LTZ and DXM groups were intraperitoneally injected with LTZ (80 mg/kg) or DXM (0.5 mg/kg) for 14 d
respectively
while the other two groups were given the equal volume of normal saline. After last challenge for 24 h
the aerosol inhalation of methacholine was performed and the airway reactivity was measured. The bronchoalveolar lavage fluid (BALF) was collected. The Wright-Giemsa staining was used for total white blood cells and differential counts. The levels of cytokines interleukin (IL)-17 and IL-10 were detected by enzyme-linked immunosorbent assay. The pathological change of lung tissue was observed by hematoxylin eosin staining. The airway responsiveness of the NA group was signifificantly higher than the normal control group (P<0.05)
while those in the LTZ and DXM groups were signifificantly lower than the NA group (P<0.05). The neutrophil and eosinophil counts in the LTZ and DXM groups were signifificantly lower than the NA group (P<0.05)
and those in the LTZ group were signifificantly lower than the DXM group (P<0.05). There were a large number of peribronchiolar and perivascular inflammatory cells in fifiltration in the NA group. The airway inflflammation in the LTZ and DXM groups were signifificantly alleviated than the NA group. The infifiltration in the LTZ group was signifificantly reduced than the DXM group. Compared with the normal control group
the IL-17 level in BALF was signifificantly increased and the IL-10 level in BALF was signifificantly decreased in the NA group (P<0.05). LTZ and DXM treatment signifificantly decreased IL-17 levels and increased IL-10 levels compared with the NA group (P<0.05)
and the changes in the above indices were more signifificant in the LTZ group (P<0.05). LTZ could alleviate the airway inflflammation in the NA mice model through increasing the IL-10 level and decreasing the IL-17 level.
Abstract
To investigate the effects of ligustrazine (LTZ) on airway inflammation in a mouse model of neutrophilic asthma (NA). Forty healthy C57BL/6 female mice were randomly divided into 4 groups using a random number table
including the normal control
NA
LTZ and dexamethasone (DXM) groups
with 10 rats in each group. The NA mice model was established by the method of ovalbumin combined with lipopolysaccharide sensitization. At 0.5 h before each challenge
LTZ and DXM groups were intraperitoneally injected with LTZ (80 mg/kg) or DXM (0.5 mg/kg) for 14 d
respectively
while the other two groups were given the equal volume of normal saline. After last challenge for 24 h
the aerosol inhalation of methacholine was performed and the airway reactivity was measured. The bronchoalveolar lavage fluid (BALF) was collected. The Wright-Giemsa staining was used for total white blood cells and differential counts. The levels of cytokines interleukin (IL)-17 and IL-10 were detected by enzyme-linked immunosorbent assay. The pathological change of lung tissue was observed by hematoxylin eosin staining. The airway responsiveness of the NA group was signifificantly higher than the normal control group (P<0.05)
while those in the LTZ and DXM groups were signifificantly lower than the NA group (P<0.05). The neutrophil and eosinophil counts in the LTZ and DXM groups were signifificantly lower than the NA group (P<0.05)
and those in the LTZ group were signifificantly lower than the DXM group (P<0.05). There were a large number of peribronchiolar and perivascular inflammatory cells in fifiltration in the NA group. The airway inflflammation in the LTZ and DXM groups were signifificantly alleviated than the NA group. The infifiltration in the LTZ group was signifificantly reduced than the DXM group. Compared with the normal control group
the IL-17 level in BALF was signifificantly increased and the IL-10 level in BALF was signifificantly decreased in the NA group (P<0.05). LTZ and DXM treatment signifificantly decreased IL-17 levels and increased IL-10 levels compared with the NA group (P<0.05)
and the changes in the above indices were more signifificant in the LTZ group (P<0.05). LTZ could alleviate the airway inflflammation in the NA mice model through increasing the IL-10 level and decreasing the IL-17 level.
关键词
Ligustrazineneutrophilic asthmaairway inflflammationcytokine
Keywords
Ligustrazineneutrophilic asthmaairway inflflammationcytokine
references
Mcgrath KW, Icitovic N, Boushey HA, Lazarus SC, Sutherland ER, Chinchilli VM, et al. A large subgroup of mild-to-moderate asthma is persistently noneosinophilic. Am J Respir Crit Care Med 2012;185:612–619.
Zhang YX, Nong GM, Liao J, Jiang M, Liang XA, Liu J. Application of induced sputum cytology analysis for childhood asthma subtype. Chin J Appl Clin Pediatr 2010;25:129–132.
Jatakanon A, Uasuf C, Maziak W, Lim S, Chung F, Barnes PJ. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 2012;160:1532–1539.
Zhao Y, Yang J, Gao YD, Guo W. Th17 immunity in patients with allergic asthma. Intern Arch Allergy Immun 2010;151:297–307.
Zhou C, Yin KS, Chen JH, Shi Y. Changes of the ratio of T helper 17 cells and the level of IL-17 in bronchial asthmatic mice. J Nanjing Med Univ (Nat Sci) 2009;29:109–112.
Zhang XP, Jiang J, Cheng QH, Ye Q, Li WJ, Zhu H, et al. Protective effects of ligustrazine, kakonein and panax notoginsenoside on the small intestine and immune organs of rats with severe acute pancreatitis. Hepatobiliary Pancreatic Dis Int 2011;10:632–637.
Liu RT, Li BZ. Clinical observation of Ligustrazine Injection adjuvant therapy 36 cases infant with bronchial asthma. China Med Herald (Chin) 2011;8:66–68.
Zhu W, Tian H. The treatment of 38 children with asthma in acute stage by tetramethylpyrazine and small dosages of tripterygioside. West J Tradit Chin Med (Chin) 2015;28:102–104.
Xie H, Sun SH. The observation of azithromycin combined ligustrazine on the treatment of glucocorticoid resistance type of asthma. Modern J Integr Tradit Chin West Med (Chin) 2003;13:987–988.
Jiang H, Chen X, Wang JY, Xue YF. Effect of ligustrazine on Th17 cell and balance of Th17/Treg in asthma model mouse. Chin J Immun 2014;10:1339–1343.
Wang YJ, Zhu HZ, Kong XC, Lu L, Liu L, Zhang Y, et al. Observation of the effect of ligustrazine on improving the airway of asthmatic rats. Chin Tradit Patent Med (Chin) 2014;36:834–837.
Wilson RH, Whitehead GS, Nakano H, Free ME, Kolls JK, Cook DN. Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness. Am J Respir Critic Care Med 2009;180:720–730.
Liu XW, Jiang M, Nong GM, Liu HY, Peng F. To establish a mice model of neutrophilic asthma and research the airway hyperreactivity. Chin J Asthma (Electronic Version) 2013;7:151–158.
Wei Y, Luo QL, Sun J, Chen MX, Liu F, Dong JC. Bu-Shen-Yi-Qi Formulae suppress chronic airway inflammation and regulate Th17/Treg imbalance in the murine ovalbumin asthma model. J Ethnopharmacol 2015;164:368–377.
Mckinley L, Alcorn JF, Peterson A, Dupont RB, Kapadia S, Logar Alision, et al. Th17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J Immun 2008;181:4089–4097.
Zhang LQ. Clinical observation of pidotimod and ligustrazine in children with bronchial asthma. Shaanxi Med J (Chin) 2013;42:355–356.
Che XW, Wang H, Zhang Y, Wang W. Effect of Ligustrazine Injection on levels of interleukin-4 and interferon-γ in patients with bronchial asthma. Chin J Integr Med 2008;14:217–220.
Pelaia G, Vatrella A, Maselli R. The potential of biologics for the treatment of asthma. Nature Rev Drug Discov 2012;11:958–972.
Qiu YY, Zhang YW, Qian XF, Bian T. MiR-371, miR-138, miR-544, miR-145, and miR-214 could modulate Th1/Th2 balance in asthma through the combinatorial regulation of Runx3. Am J Transl Res 2017;9:3184–3199.
Wang ZE, Zhou XN, Yang Yi, Liu ZY. Effect of Jian'erle Granule on Th17/Treg imbalance of asthma mice. Chin J Integr Med 2016;36:1510–1514.
Henness S, Van TE, Ge Q, Armour CL, Hughes JM, Ammit AJ. IL-17A acts via p38 MAPK to increase stability of TNFalpha-induced IL-8 mRNA in human ASM. Am J Physiol Lung Cell Mol Physiol 2006;290:1283–1290.
Newcomb DC, Jr PR. Th17-mediated inflammation in asthma. Current Opin Immun 2013;25:755–760.
Eusebio M, Kuna P, Kraszula L, Kupczyk M, Pietruczuk M. The relative values of CD8+CD25+Foxp3 brigh Treg cells correlate with selected lung function parameters in asthma. Int J Immunopath Pharmac 2015;28:218–226.
Chen CR, Deng JM, Gong C, Zou XY, Wei X, Yang ML, et al. Study on the imbalance of IL-1, IL-10 and IL-4, IFN-γ in peripheral blood of chronic persistent allergic bronchial asthma. J Guangxi Med Univ (Chin) 2014;31:414–415.
Shi YH, Shi GC, Wan HY, Jiang LH, Ai XY, Zhu HX, et al. The prevalence of blood Thl7 and CD4+CD25+ Treg cells in patients with bronchial asthma. Chin J Immun (Chin) 2010;26:740–743.
Huber S, Gagliani N, Esplugues E, Jr WO, Huber FJ, Chaudhry A, et al. Th17 cells express interleukin-10 receptor and are controlled by Foxp3–, and Foxp3+, regulatory CD4+, T cells in an interleukin-10-dependent manner. Immunity 2011;34:554–565.
0
浏览量
0
Downloads
2
CSCD
- Meta-XML下载
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
关联资源
相关文章
相关作者
相关机构
- 邮编：100091
- 联系电话：010-62886827, 62877592 传真：010-62874291
- 技术支持由北京北大方正电子有限公司提供 京ICP备05067934号-1
京公网安备11010802024621 - 本系统建议在Chrome、 IE9+ 以上版本浏览器阅读本站内容，360浏览器请切换至极速模式
- Cookies帮助我们提供服务并提供个性化体验。使用本网站，即表示您同意我们使用Cookies
